RETRACTED: Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic
- 1 February 2007
- Vol. 72 (2) , 180-187
- https://doi.org/10.1016/j.steroids.2006.11.014
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Acting via a Cell Surface Receptor, Thyroid Hormone Is a Growth Factor for Glioma CellsCancer Research, 2006
- Cell Growth Effects of Triiodothyronine and Expression of Thyroid Hormone Receptor in Prostate Carcinoma CellsJournal of Andrology, 2005
- Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires αvβ3Blood, 2004
- The Thyroid Hormone Receptor Is a Suppressor of ras-Mediated Transcription, Proliferation, and TransformationMolecular and Cellular Biology, 2004
- Proangiogenic Action of Thyroid Hormone Is Fibroblast Growth Factor–Dependent and Is Initiated at the Cell SurfaceCirculation Research, 2004
- Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cellsBritish Journal of Cancer, 2004
- Resveratrol Induces Apoptosis in Thyroid Cancer Cell Lines via a MAPK- and p53-Dependent MechanismJournal of Clinical Endocrinology & Metabolism, 2002
- Thyroid Hormone-Induced Cell Proliferation in GC Cells Is Mediated by Changes in G1 Cyclin/Cyclin-Dependent Kinase Levels and ActivityEndocrinology, 1999
- Thyroid hormone promotes the phosphorylation of STAT3 and potentiates the action of epidermal growth factor in cultured cellsBiochemical Journal, 1999
- Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaPMolecular and Cellular Endocrinology, 1995